Mechanism of Action Tirzepatide: Works on two hormones (GLP-1 and GIP)
Finally, GLP-1 patch popularity growth is led by Kind Patches, Gentle Patches and Oceaura
The 10mg vial suits pilot studies and method development, where committing a larger mass to one reconstitution date would waste material
Incretin agonism reduces appetite, promotes insulin release, and slows gastric transit, which together lead to profound weight loss with improvements in metabolism 16
Many patients find this region comfortable and accessible for self-injection
Until these trials are complete and regulatory submissions are made to bodies such as the MHRA or EMA, retatrutide remains an investigational agent and is not available as a licensed treatment in the UK